Drug Trial Radar · NCT05033080
A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)
Last checked: Nov 19, 2026Latest source record: Oct 3, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
435
Actual
Start
Sep 14, 2021
Primary completion
May 12, 2023
Study completion Nov 21, 2023
Sponsor
- Lead sponsor
- Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
- Sponsor type
- Industry
- First posted
- Sep 2, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study evaluates the efficacy and safety of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in CF participants who were heterozygous for F508del and a minimal function mutation (F/MF participants).
Conditions
- Cystic Fibrosis
Interventions
VX-121/TEZ/D-IVADrug
Fixed-dose combination tablets for oral administration.
ELX/TEZ/IVADrug
Fixed-dose combination tablets for oral administration.
IVADrug
Tablet for oral administration.
Placebo (matched to VX-121/TEZ/D-IVA)Drug
Placebo matched to VX-121/TEZ/D-IVA for oral administration.
Placebo (matched to ELX/TEZ/IVA)Drug
Placebo matched to ELX/TEZ/IVA for oral administration.
Placebo (matched to IVA)Drug
Placebo matched to IVA for oral administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute Change in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1)Time frame: From Baseline Through Week 24
Locations
139 sites in 12 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Banner University of Arizona Medical Center
Tucson, Arizona
Arkansas Children's Hospital
Little Rock, Arkansas
Miller Children's Hospital / Long Beach Memorial
Long Beach, California
Children's Hospital Los Angeles
Los Angeles, California
Kaiser Permanente
Oakland, California
University of California Davis Medical Center
Sacramento, California
University of California San Francisco, Lung Transplant Program
San Francisco, California
Children's Hospital of Colorado
Aurora, Colorado
National Jewish Health
Denver, Colorado
University of Florida, Shands Hospital
Gainesville, Florida
Joe DiMaggio Cystic Fibrosis & Pulmonary Center
Hollywood, Florida
Central Florida Pulmonary Group, PA
Orlando, Florida
Nemours Children's Hospital
Orlando, Florida
Johns Hopkins All Children's Hospital Outpatient Care Center
St. Petersburg, Florida
The Emory Clinic at Chantilly
Atlanta, Georgia
Augusta University
Augusta, Georgia
St. Luke's Cystic Fibrosis Center of Idaho
Boise, Idaho
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
Northwestern Memorial Hospital
Chicago, Illinois
Indiana University
Indianapolis, Indiana
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana
University of Kansas Medical Center
Kansas City, Kansas
University of Kentucky
Lexington, Kentucky
Kosair Charities Pediatric Clinical Research Unit
Louisville, Kentucky
Tulane Medical Center
New Orleans, Louisiana
Massachusetts General Hospital Cystic Fibrosis Center Clinical Rsearch Center
Boston, Massachusetts
Boston Children's Hospital
Boston, Massachusetts
UMass Memorial Medical Center
Worcester, Massachusetts
Michigan Medicine
Ann Arbor, Michigan
Helen DeVos Children's Hospital CF Center
Grand Rapids, Michigan
University of Minnesota
Minneapolis, Minnesota
University of Mississippi Medical Center
Jackson, Mississippi
Childrens Hospital University of Missouri Health Sciences Center
Columbia, Missouri
The Children's Mercy Hospital
Kansas City, Missouri
Cardinal Glennon Children's Hospital - St. Louis University
St Louis, Missouri
Washington University School of Medicine / St. Louis Children's Hospital
St Louis, Missouri
Billings Clinic
Billings, Montana
Nebraska Medical Center
Omaha, Nebraska
Dartmouth Hitchcock, Manchester
Manchester, New Hampshire
Showing 40 of 139 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.